Bial

Its sale to Allergan was called off at the last minute. One year later, a biotech co-founded by Henri Termeer finds a new buyer
Endpoints
Thu, 10/1/20 - 10:01 am
Lysosomal Therapeutics
Allergan
R&D
M&A
Henri Termeer
Bial
Bial and Eisai confirm effectiveness of epilepsy monotherapy Zebinix
Pharmaceutical Business Review
Tue, 10/9/18 - 09:49 am
Bial
Eisai
Zebinix
epilepsy
focal-onset epilepsy
Neurocrine adds a Parkinson’s drug to its late-stage pipeline in $145M deal
Endpoints
Thu, 02/9/17 - 09:24 pm
Neurocrine
Parkinson's Disease
Ongentys
Bial
French drug trial suspended after participant left brain dead, five others critically ill
BioPharma Dive
Fri, 01/15/16 - 02:41 pm
France
clinical trials
cannabis
Bial